Chinese | Cancer and Vocabulary | Join Us  | Contact  
 
 About Us
 Product
Oncolytic Adenovirus therapy agents
 
H101 (Oncorine)
 
H102
 
H103 (Ad-HE)
Recombinant Gene Technology
 
rhG-CSF (SunGran)
 
 Cancer is the disease of this century:all around the world,10 million people, including 4.4 million in Asia,are suffering from a cancer.Yet,even if medical research is making progress,there is still a real lack of treatments for advanced stage cancer.This is why Sunway Biotech Co.,Ltd became involved in the battle against cancer in 1995 with the aim of developing and creating innovative therapies for unmet medical needs in the treatment of cancer, and new supporting care, to help the patients to recover better.(see About us).
 In the pursuit of that aim, Sunway Biotech's research efforts were recently rewarded as one of its products has been allowed on the market (Sungran or rhG-CSF) and another is on its way to being introduced to the market (H101).Sunway is also in the process of developing other new products such as H102 and H103 (see Clinical trial).It is therefore quite obvious that Sunway Biotech Co.,Ltd is gaining momentum and is to be seriously reckoned with in this particular trade as a rising and striving company.
 But Sunway Biotech Co.,Ltd neither wants to rest on its laurels nor wants to confine its action to the sole field of cancer.Sunway Biotech Co.,Ltd hopes to extend its field of research (see Research and Development) to other medical areas, taking advantage of its experience,relations and installations (see Business Development).
 We hope you will find all the data you are looking for on this website. We thank you for your interest in our company and invite you to contact us if you need any other kind of information!(see Contact Us)
copyright © 版权 2006 Sunway Biotech Co.,Ltd